Skip to main content

Advertisement

SpringerLink
Log in

Surgical management considerations in cystic prolactinomas—a single center case series

  • Endocrine Surgery
  • Published:
Endocrine Aims and scope Submit manuscript

Abstract

Purpose

The optimal treatment of prolactinomas with a predominantly cystic component remains poorly defined. The cystic tumor component is considered to respond less favorably to medical treatment, thereby advocating surgical management. The purpose of this study was to assess remission rates in surgically treated cystic prolactinomas, and to compare outcomes to similarly treated solid micro- and macroprolactinomas.

Methods

Clinical and imaging data were retrospectively compiled from 56 patients who underwent transsphenoidal resection, for symptomatic prolactinomas, from 2004 to 2018, at a single academic institution. Pituitary adenomas were subdivided according to tumor size and tumor consistency: cystic prolactinomas (>50% cystic tumor component) n = 17; solid microprolactinomas (<10 mm) n = 10; and solid macroprolactinomas (≥10 mm) n = 29. Remission was defined as a prolactin level of <10 ng/dl either immediately postoperative or at a later time point.

Results

Median tumor size was 15 mm for cystic prolactinomas, 7 mm for solid microprolactinomas, and 25.5 mm for solid macroprolactinomas. Remission was achieved in 76% (n = 13/17) of surgically treated cystic prolactinomas, 100% (n = 10/10) of solid microprolactinomas, and 24% (n = 7/29) of solid macroprolactinomas. More than 44% of solid macroprolactinomas had a Knosp grade > 3, while most cystic prolactinomas (93.8%) and all solid microprolactinomas (100%) had a Knosp grade ≤ 2.

Conclusions

Despite their large tumor size (≥10 mm), high remission rates can be expected with surgically treated cystic prolactinomas. This case series of cystic prolactinomas demonstrates the successful use of transsphenoidal surgery as a favorable, and a potentially curative alternative to dopaminergic therapy in this patient population.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1: MRI Characteristics of the Prolactinoma Subgroups.
Fig. 2: Surgical Remission Rates between the Prolactinoma Subgroups.

Similar content being viewed by others

References

  1. F.F. Casanueva, M.E. Molitch, J.A. Schlechte, R. Abs, V. Bonert, M.D. Bronstein, T. Brue, P. Cappabianca, A. Colao, R. Fahlbusch, H. Fideleff, M. Hadani, P. Kelly, D. Kleinberg, E. Laws, J. Marek, M. Scanlon, L.G. Sobrinho, J.A. Wass, A. Giustina, Guidelines of the pituitary society for the diagnosis and management of prolactinomas. Clin. Endocrinol. 65(2), 265–273 (2006). https://doi.org/10.1111/j.1365-2265.2006.02562.x

    Article  Google Scholar 

  2. J.N. Carter, J.E. Tyson, G. Tolis, S. Van Vliet, C. Faiman, H.G. Friesen, Prolactin-screening tumors and hypogonadism in 22 men. N. Engl. J. Med 299(16), 847–852 (1978). https://doi.org/10.1056/NEJM197810192991602

    Article  CAS  PubMed  Google Scholar 

  3. M.P. Gillam, M.E. Molitch, G. Lombardi, A. Colao, Advances in the treatment of prolactinomas. Endocr. Rev. 27(5), 485–534 (2006). https://doi.org/10.1210/er.2005-9998

    Article  CAS  PubMed  Google Scholar 

  4. S. Melmed, F.F. Casanueva, A.R. Hoffman, D.L. Kleinberg, V.M. Montori, J.A. Schlechte, J.A. Wass, S. Endocrine, Diagnosis and treatment of hyperprolactinemia: an Endocrine Society clinical practice guideline. J. Clin. Endocrinol. Metab. 96(2), 273–288 (2011). https://doi.org/10.1210/jc.2010-1692

    Article  CAS  PubMed  Google Scholar 

  5. W.J. Inder, M.R. Macfarlane, Hyperprolactinaemia associated with a complex cystic pituitary mass: medical versus surgical therapy. Intern. Med. J. 34(9–10), 573–576 (2004). https://doi.org/10.1111/j.1445-5994.2004.00675.x

    Article  CAS  PubMed  Google Scholar 

  6. World Medical Association, Declaration of Helsinki. Ethical principles for medical research involving human subjects. J. Indian Med. Assoc. 107(6), 403–405 (2009)

    Google Scholar 

  7. R.A. Agha, A.J. Fowler, S. Rajmohan, I. Barai, D.P. Orgill, P. Group, Preferred reporting of case series in surgery; the PROCESS guidelines. Int J. Surg. 36(Pt A), 319–323 (2016). https://doi.org/10.1016/j.ijsu.2016.10.025

    Article  PubMed  Google Scholar 

  8. G. Mohr, J. Hardy, Hemorrhage, necrosis, and apoplexy in pituitary adenomas. Surg. Neurol. 18(3), 181–189 (1982)

    Article  CAS  Google Scholar 

  9. E. Knosp, E. Steiner, K. Kitz, C. Matula, Pituitary adenomas with invasion of the cavernous sinus space: a magnetic resonance imaging classification compared with surgical findings. Neurosurgery 33(4), 610–617 (1993). discussion 617–618

    CAS  PubMed  Google Scholar 

  10. A.S. Micko, A. Wohrer, S. Wolfsberger, E. Knosp, Invasion of the cavernous sinus space in pituitary adenomas: endoscopic verification and its correlation with an MRI-based classification. J. Neurosurg. 122(4), 803–811 (2015). https://doi.org/10.3171/2014.12.JNS141083

    Article  PubMed  Google Scholar 

  11. S. Nakasu, Y. Nakasu, K. Kyoshima, K. Watanabe, J. Handa, H. Okabe, Pituitary adenoma with multiple ciliated cysts: transitional cell tumor? Surg. Neurol. 31(1), 41–48 (1989)

    Article  CAS  Google Scholar 

  12. G.S. Pearl, Y. Takei, M. Kurisaka, S. Seyama, G.T. Tindall, Cystic prolactinoma: a variant of “transitional cell tumor” of the pituitary. Am. J. Surg. Pathol. 5(1), 85–90 (1981)

    Article  CAS  Google Scholar 

  13. B. Bahuleyan, G. Menon, S. Nair, B.R. Rao, H.V. Easwer, K. Krishna, Non-surgical management of cystic prolactinomas. J. Clin. Neurosci. 16(11), 1421–1424 (2009). https://doi.org/10.1016/j.jocn.2009.03.024

    Article  PubMed  Google Scholar 

  14. A. Faje, P. Chunharojrith, J. Nency, B.M. Biller, B. Swearingen, A. Klibanski, Dopamine agonists can reduce cystic prolactinomas. J. Clin. Endocrinol. Metab. 101(10), 3709–3715 (2016). https://doi.org/10.1210/jc.2016-2008

    Article  CAS  PubMed  Google Scholar 

  15. A. Colao, Pituitary tumours: the prolactinoma. Best. Pr. Res Clin. Endocrinol. Metab. 23(5), 575–596 (2009). https://doi.org/10.1016/j.beem.2009.05.003

    Article  CAS  Google Scholar 

  16. A.P. Amar, W.T. Couldwell, J.C. Chen, M.H. Weiss, Predictive value of serum prolactin levels measured immediately after transsphenoidal surgery. J. Neurosurg. 97(2), 307–314 (2002). https://doi.org/10.3171/jns.2002.97.2.0307

    Article  CAS  PubMed  Google Scholar 

  17. R. Fahlbusch, M. Buchfelder, Transsphenoidal surgery of parasellar pituitary adenomas. Acta Neurochir. 92(1–4), 93–99 (1988)

    Article  CAS  Google Scholar 

  18. X.F. Shou, S.Q. Li, Y.F. Wang, Y. Zhao, P.F. Jia, L.F. Zhou, Treatment of pituitary adenomas with a transsphenoidal approach. Neurosurgery 56(2), 249–256 (2005). discussion 249–256

    Article  Google Scholar 

  19. J.P. Sheehan, D. Kondziolka, J. Flickinger, L.D. Lunsford, Radiosurgery for residual or recurrent nonfunctioning pituitary adenoma. J. Neurosurg. 97(5 Suppl), 408–414 (2002). https://doi.org/10.3171/jns.2002.97. supplement

    Article  PubMed  Google Scholar 

  20. E. Delgrange, T. Gustin, Cystic macroprolactinoma: primary medical treatment? Intern. Med. J. 35(11), 687 (2005). https://doi.org/10.1111/j.1445-5994.2005.00941.x. author reply 688

    Article  CAS  PubMed  Google Scholar 

  21. J. Kreutzer, R. Buslei, H. Wallaschofski, B. Hofmann, C. Nimsky, R. Fahlbusch, M. Buchfelder, Operative treatment of prolactinomas: indications and results in a current consecutive series of 212 patients. Eur. J. Endocrinol. 158(1), 11–18 (2008). https://doi.org/10.1530/EJE-07-0248

    Article  CAS  PubMed  Google Scholar 

  22. T. Ogiwara, T. Horiuchi, A. Nagm, T. Goto, K. Hongo, Significance of surgical management for cystic prolactinoma. Pituitary 20(2), 225–230 (2017). https://doi.org/10.1007/s11102-016-0766-6

    Article  CAS  PubMed  Google Scholar 

  23. C. Zhang, X. Ding, Y. Lu, L. Hu, G. Hu, Cerebrospinal fluid rhinorrhoea following transsphenoidal surgery for pituitary adenoma: experience in a Chinese centre. Acta Otorhinolaryngol. Ital. 37(4), 303–307 (2017). https://doi.org/10.14639/0392-100X-1086

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  24. M. Menucci, A. Quinones-Hinojosa, P. Burger, R. Salvatori, Effect of dopaminergic drug treatment on surgical findings in prolactinomas. Pituitary 14(1), 68–74 (2011). https://doi.org/10.1007/s11102-010-0261-4

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  25. A.S. Dumont, E.C. Nemergut 2nd, J.A. Jane Jr., E.R. Laws Jr., Postoperative care following pituitary surgery. J. Intensive Care Med. 20(3), 127–140 (2005). https://doi.org/10.1177/0885066605275247

    Article  PubMed  Google Scholar 

  26. P.R. Jethwa, T.D. Patel, A.F. Hajart, J.A. Eloy, W.T. Couldwell, J.K. Liu, Cost-Effectiveness Analysis of Microscopic and Endoscopic Transsphenoidal Surgery Versus Medical Therapy in the Management of Microprolactinoma in the United States. World Neurosurg. 87, 65–76 (2016). https://doi.org/10.1016/j.wneu.2015.10.090

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

We thank Patrick William Hosokawa for the support in statistical analysis, Surgical Outcome and Applied Research, Department of Surgery, University of Colorado School of Medicine.

Author information

Authors and Affiliations

  1. Department of Neurosurgery, University of Colorado School of Medicine, Aurora, CO, USA

    Edin Nevzati, Grégoire P. Chatain & Kevin O. Lillehei

  2. Division of Neurosurgery, University of Missouri School of Medicine, Columbia, MO, USA

    Steven B. Carr

  3. Department of Medicine, Division of Endocrinology, Metabolism and Diabetes, University of Colorado School of Medicine, Aurora, CO, USA

    Janice M. Kerr

Authors
  1. Edin Nevzati
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Grégoire P. Chatain
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Steven B. Carr
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Kevin O. Lillehei
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Janice M. Kerr
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Edin Nevzati.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Nevzati, E., Chatain, G.P., Carr, S.B. et al. Surgical management considerations in cystic prolactinomas—a single center case series. Endocrine 67, 58–66 (2020). https://doi.org/10.1007/s12020-019-02076-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12020-019-02076-8

Keywords

Search

Navigation